Evidence of the ability of inflammation to both initiate and fuel cancer has been accumulating since at least the 1980s. In fact, any chronic inflammatory disease – such as arthritis, bronchitis, fasciitis, colitis, and asthma – can increase the risk of cancer. For example, according to a 2000 study, approximately one in every ten patients with ulcerative colitis will eventually develop colorectal cancer. By another estimate, chronic inflammation may precede at least one-third of all cancers. However, it isn’t just the risk of cancer that is a concern when chronic inflammation is present.
A study published in the May 2009 issue of the Journal of Clinical Oncology demonstrated that patients with high blood levels of C-reactive protein (CRP) and serum amyloid A (SAA) were two to three times more likely to die prematurely or have their cancer return than patients with lower levels. Continue reading